Lataa...
Management of clozapine treatment during the COVID-19 pandemic
Clozapine is the only available treatment for refractory schizophrenia but its use involves frequent physical contact with healthcare workers for the purpose of mandatory blood monitoring. During the COVID-19 pandemic, patients taking clozapine will be self-isolating to reduce the risk of infection,...
Tallennettuna:
| Julkaisussa: | Ther Adv Psychopharmacol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7256815/ https://ncbi.nlm.nih.gov/pubmed/32542111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125320928167 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|